BOSTON SCIENTIFIC CORP

BSXSEC EDGAR

Surgical & Medical Instruments & Apparatus(DE)CIK: 885725

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$14.2B	$12.7B	$11.9B	$9.9B	$10.7B
Cost of Goods and Services Sold	$4.3B	$4.0B	$3.7B	$3.5B	$3.1B
Gross Profit	$9.9B	$8.7B	$8.2B	$6.4B	$7.6B
Selling, General and Administrative Expense	$5.2B	$4.5B	$4.4B	$3.8B	$3.9B
Operating Expenses	$7.6B	$7.1B	$7.0B	$6.5B	$6.1B
Operating Income (Loss)	$2.3B	$1.6B	$1.2B	-$80.0M	$1.5B
Interest Expense	$265.0M	$470.0M	$341.0M	$361.0M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$39.4B	$35.1B	$32.5B	$32.2B	$30.8B
Assets, Current	$6.9B	$6.5B	$5.8B	$6.3B	$6.7B
Cash and Cash Equivalents, at Carrying Value	$865.0M	$928.0M	$1.9B	$1.7B	$217.0M
Inventory, Net	$2.8B	$2.5B	$1.9B	$1.6B	$1.4B
Liabilities, Current	$6.4B	$4.9B	$3.8B	$4.3B	$3.7B
Long-term Debt	—	—	—	—	—
Accounts Payable, Current	$960.0M	$942.0M	$862.0M	$794.0M	$513.0M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$2.5B	$1.5B	$1.9B	$1.5B	$1.8B
Net Cash Provided by (Used in) Investing Activities	-$2.6B	-$2.0B	-$1.6B	-$411.0M	-$5.0B
Net Cash Provided by (Used in) Financing Activities	$5.0M	-$548.0M	-$95.0M	$293.0M	$3.0B
Payments to Acquire Property, Plant, and Equipment	$711.0M	$588.0M	$554.0M	$376.0M	$461.0M
Payments of Dividends	—	$55.0M	$55.0M	$28.0M	$0.00
Payments for Repurchase of Common Stock	—	—	—	$535.0M	$0.00

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)